MediNice SA · FWB:77E

MediNice SA financial statements

MediNice SA's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in PLN

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue0188.0K225.0K246.0K285.0K372.0K164.4K1.11K243.0K184.7K
Cost of revenue166.0K214.0K150.0K111.0K74.0K122.0K29.2K23.3K15.0K15.1K
Gross profit-166.0K-26.0K75.0K135.0K214.0K250.0K135.2K-22.2K228.0K169.6K
Research and development6.00K75.0K75.0K85.0K80.0K69.0K
Selling, general and administrative1.36M1.36M1.52M1.26M1.02M643.9K434.9K
Operating income-6.78M37.2M-5.78M-5.00M-3.29M-2.46M-1.98M-1.73M-618.0K-303.5K
Depreciation and amortization242.0K230.0K358.0K314.0K362.0K362.0K99.3K51.0K6.67K7.93K
EBITDA-6.54M37.5M-5.42M-4.68M-2.92M-2.10M-1.88M-1.68M-611.4K-295.6K
Interest expense42.0K52.0K62.0K75.0K59.0K47.0K10.0K9.17K25.7K15.6K
Income before tax-6.74M37.6M-5.07M-4.92M-2.88M-3.02M-2.02M-1.73M-645.0K-319.8K
Income tax-14.0K-25.0K010.0K228.5K5.88K502138
Net income-6.72M37.6M-5.07M-4.92M-2.88M-3.02M-2.25M-1.65M-507.2K-320.6K
Earnings per share, basic-0.805.62-0.79-0.79-0.50-0.56-0.51-0.50-0.15-0.10
Earnings per share, diluted-0.77-0.48

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents9.60M9.12M10.3M21.2M31.9M11.5M5.51M3.54M1.85M3.81K
Short-term investments3.00K630.0K75.0K22.0K25.9K10.00K-85.2K
Receivables6.00K701.0K583.0K741.0K918.0K691.0K391.0K2.23M820.7K807.3K
Inventory3.72M-445.0K
Current assets9.95M9.85M10.9M21.9M32.9M13.4M10.7M5.97M3.49M885.0K
Property, plant and equipment831.0K532.0K996.0K1.21M29.5K41.5K
Goodwill47.7M47.7M0000152.0K152.2K121.2K
Total assets92.7M86.6M37.5M41.9M49.1M20.9M11.7M7.55M4.90M1.46M
Accounts payable312.0K981.0K752.0K625.0K379.0K274.0K924.0K197.7K104.0K181.7K
Current liabilities1.45M2.46M1.16M1.01M1.16M1.38M2.94M4.48M660.5K195.0K
Long-term debt00000236.0K509.3K149.4K127.0K
Total debt365.0K346.0K506.0K582.0K764.0K351.0K509.3K149.4K127.0K219.4K
Total liabilities4.62M5.59M4.33M4.77M8.60M3.94M3.46M4.64M1.64M1.30M
Shareholders' equity88.1M81.0M33.2M37.1M40.5M17.0M8.23M2.92M3.26M151.9K
Shares outstanding8.45M6.68M6.40M6.43M5.76M5.36M4.36M3.34M3.34M3.34M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-5.58M-3.65M-3.45M-2.79M-1.71M-3.26M-5.14M-1.89M-1.70M-625.4K
Capital spending-6.07M-3.00K-6.47M-448.0K-314.0K-82.0K-907.3K-39.1K-30.8K-31.2K
Free cash flow-11.7M-3.66M-9.92M-3.24M-2.02M-6.23M-6.04M-1.93M-1.73M-656.5K
Cash from investing-6.07M-7.34M-6.73M-4.12M-6.63M-2.49M-1.03M-138.0K-44.8K-31.2K
Cash from financing12.1M9.80M-691.0K-3.85M28.7M11.8M8.13M3.73M3.58M525.4K
Share buybacks11.5M7.59M1.30M3.62M
Change in cash481.0K-1.20M-10.9M-10.8M20.4M6.02M1.97M1.70M1.84M-131.1K